Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082174358> ?p ?o ?g. }
- W2082174358 endingPage "411.e9" @default.
- W2082174358 startingPage "400" @default.
- W2082174358 abstract "BackgroundThe capacity of CD8+ T cells to control infections and mediate antitumor immunity requires the development and survival of effector and memory cells. IL-21 has emerged as a potent inducer of CD8+ T-cell effector function and memory development in mouse models of infectious disease. However, the role of IL-21 and associated signaling pathways in protective CD8+ T-cell immunity in human subjects is unknown.ObjectiveWe sought to determine which signaling pathways mediate the effects of IL-21 on human CD8+ T cells and whether defects in these pathways contribute to disease pathogenesis in patients with primary immunodeficiencies caused by mutations in components of the IL-21 signaling cascade.MethodsHuman primary immunodeficiencies resulting from monogenic mutations provide a unique opportunity to assess the requirement for particular molecules in regulating human lymphocyte function. Lymphocytes from patients with loss-of-function mutations in signal transducer and activator of transcription 1 (STAT1), STAT3, or IL-21 receptor (IL21R) were used to assess the respective roles of these genes in human CD8+ T-cell differentiation in vivo and in vitro.ResultsMutations in STAT3 and IL21R, but not STAT1, led to a decrease in multiple memory CD8+ T-cell subsets in vivo, indicating that STAT3 signaling, possibly downstream of IL-21R, regulates the memory cell pool. Furthermore, STAT3 was important for inducing the lytic machinery in IL-21–stimulated naive CD8+ T cells. However, this defect was overcome by T-cell receptor engagement.ConclusionThe IL-21R/STAT3 pathway is required for many aspects of human CD8+ T-cell behavior but in some cases can be compensated by other signals. This helps explain the relatively mild susceptibility to viral disease observed in STAT3- and IL-21R–deficient subjects. The capacity of CD8+ T cells to control infections and mediate antitumor immunity requires the development and survival of effector and memory cells. IL-21 has emerged as a potent inducer of CD8+ T-cell effector function and memory development in mouse models of infectious disease. However, the role of IL-21 and associated signaling pathways in protective CD8+ T-cell immunity in human subjects is unknown. We sought to determine which signaling pathways mediate the effects of IL-21 on human CD8+ T cells and whether defects in these pathways contribute to disease pathogenesis in patients with primary immunodeficiencies caused by mutations in components of the IL-21 signaling cascade. Human primary immunodeficiencies resulting from monogenic mutations provide a unique opportunity to assess the requirement for particular molecules in regulating human lymphocyte function. Lymphocytes from patients with loss-of-function mutations in signal transducer and activator of transcription 1 (STAT1), STAT3, or IL-21 receptor (IL21R) were used to assess the respective roles of these genes in human CD8+ T-cell differentiation in vivo and in vitro. Mutations in STAT3 and IL21R, but not STAT1, led to a decrease in multiple memory CD8+ T-cell subsets in vivo, indicating that STAT3 signaling, possibly downstream of IL-21R, regulates the memory cell pool. Furthermore, STAT3 was important for inducing the lytic machinery in IL-21–stimulated naive CD8+ T cells. However, this defect was overcome by T-cell receptor engagement. The IL-21R/STAT3 pathway is required for many aspects of human CD8+ T-cell behavior but in some cases can be compensated by other signals. This helps explain the relatively mild susceptibility to viral disease observed in STAT3- and IL-21R–deficient subjects." @default.
- W2082174358 created "2016-06-24" @default.
- W2082174358 creator A5001380464 @default.
- W2082174358 creator A5005206087 @default.
- W2082174358 creator A5010045339 @default.
- W2082174358 creator A5016237829 @default.
- W2082174358 creator A5022097331 @default.
- W2082174358 creator A5024087517 @default.
- W2082174358 creator A5025155115 @default.
- W2082174358 creator A5027300481 @default.
- W2082174358 creator A5031536047 @default.
- W2082174358 creator A5032223113 @default.
- W2082174358 creator A5033794423 @default.
- W2082174358 creator A5036013278 @default.
- W2082174358 creator A5038299372 @default.
- W2082174358 creator A5043002032 @default.
- W2082174358 creator A5047928635 @default.
- W2082174358 creator A5050011116 @default.
- W2082174358 creator A5053440227 @default.
- W2082174358 creator A5057216230 @default.
- W2082174358 creator A5058891305 @default.
- W2082174358 creator A5063790935 @default.
- W2082174358 creator A5068462189 @default.
- W2082174358 creator A5075212731 @default.
- W2082174358 creator A5077913296 @default.
- W2082174358 creator A5078211882 @default.
- W2082174358 creator A5083070243 @default.
- W2082174358 creator A5085549134 @default.
- W2082174358 creator A5087814317 @default.
- W2082174358 date "2013-08-01" @default.
- W2082174358 modified "2023-10-18" @default.
- W2082174358 title "Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8+ T-cell memory formation and function" @default.
- W2082174358 cites W1495069682 @default.
- W2082174358 cites W1563636366 @default.
- W2082174358 cites W1574493485 @default.
- W2082174358 cites W1575016278 @default.
- W2082174358 cites W1601504908 @default.
- W2082174358 cites W1603553128 @default.
- W2082174358 cites W1672186364 @default.
- W2082174358 cites W1753039009 @default.
- W2082174358 cites W1827723601 @default.
- W2082174358 cites W1939229836 @default.
- W2082174358 cites W1964077677 @default.
- W2082174358 cites W1965548419 @default.
- W2082174358 cites W1967181958 @default.
- W2082174358 cites W1969294545 @default.
- W2082174358 cites W1970728276 @default.
- W2082174358 cites W1973601490 @default.
- W2082174358 cites W1974842026 @default.
- W2082174358 cites W1976019359 @default.
- W2082174358 cites W1976355501 @default.
- W2082174358 cites W1976785514 @default.
- W2082174358 cites W1981302308 @default.
- W2082174358 cites W1981480494 @default.
- W2082174358 cites W1982323892 @default.
- W2082174358 cites W1985489508 @default.
- W2082174358 cites W1990555844 @default.
- W2082174358 cites W1991271747 @default.
- W2082174358 cites W1992443284 @default.
- W2082174358 cites W1995297089 @default.
- W2082174358 cites W1995928670 @default.
- W2082174358 cites W1996005331 @default.
- W2082174358 cites W2006027051 @default.
- W2082174358 cites W2016804485 @default.
- W2082174358 cites W2021806738 @default.
- W2082174358 cites W2027265343 @default.
- W2082174358 cites W2043901802 @default.
- W2082174358 cites W2052664182 @default.
- W2082174358 cites W2057599316 @default.
- W2082174358 cites W2057877742 @default.
- W2082174358 cites W2058299927 @default.
- W2082174358 cites W2060924363 @default.
- W2082174358 cites W2061014664 @default.
- W2082174358 cites W2068005505 @default.
- W2082174358 cites W2072170105 @default.
- W2082174358 cites W2072753651 @default.
- W2082174358 cites W2073449362 @default.
- W2082174358 cites W2074572906 @default.
- W2082174358 cites W2076723714 @default.
- W2082174358 cites W2084274092 @default.
- W2082174358 cites W2084409051 @default.
- W2082174358 cites W2085600062 @default.
- W2082174358 cites W2085921835 @default.
- W2082174358 cites W2093360377 @default.
- W2082174358 cites W2095939112 @default.
- W2082174358 cites W2104411113 @default.
- W2082174358 cites W2104497596 @default.
- W2082174358 cites W2106166533 @default.
- W2082174358 cites W2107377230 @default.
- W2082174358 cites W2112966339 @default.
- W2082174358 cites W2114263643 @default.
- W2082174358 cites W2115779634 @default.
- W2082174358 cites W2116521901 @default.
- W2082174358 cites W2131814542 @default.
- W2082174358 cites W2133588094 @default.
- W2082174358 cites W2137564018 @default.
- W2082174358 cites W2137698324 @default.
- W2082174358 cites W2141312960 @default.